The MTT assay is a gold-standard colorimetric technique for quantitatively measuring cell viability and cytotoxicity in vitro, serving as the primary method for medical device biocompatibility testing under ISO 10993-5. This comprehensive technical guide explains the underlying principle, applicable sample types, testing items, step-by-step methodology, acceptance criteria, and practical applications of the MTT cytotoxicity evaluation experiment.
Technical Overview
The MTT assay is one of the most widely adopted in vitro methods for evaluating cellular metabolic activity as a quantitative indicator of cell viability and cytotoxicity. First introduced by Mosmann in 1983, the technique has become a cornerstone of biocompatibility testing, drug screening, and toxicological research worldwide. Its enduring popularity stems from its simplicity, reproducibility, high throughput capability using standard 96-well microplates, and compatibility with widely available spectrophotometric laboratory equipment.
Principle of the MTT Assay
MTT is a yellow, water-soluble tetrazolium salt with the chemical name 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. In living, metabolically active cells, mitochondrial succinate dehydrogenase and other intracellular reductases cleave the tetrazolium ring, converting MTT into insoluble purple formazan crystals that accumulate within the cells and are precipitated near the cell surface. Dead or metabolically inactive cells lack functional dehydrogenase enzymes and therefore cannot perform this reduction. After the incubation period, the formazan crystals are dissolved in a solubilization solution such as dimethyl sulfoxide (DMSO) or acidified isopropanol, producing a homogeneous purple-colored solution whose optical density is measured spectrophotometrically at a wavelength of approximately 570 nm, typically with a reference wavelength between 630 and 690 nm to correct for optical interference.
Because the amount of formazan produced is directly proportional to the number of viable cells and their enzymatic activity within a defined linear range, the measured absorbance provides a reliable quantitative measure of cell viability. Comparing the absorbance of cells exposed to a test sample against that of untreated negative control cells yields a percentage viability value, which forms the basis of cytotoxicity classification.
Key Advantages of the Method
- Quantitative and objective results, avoiding subjective microscopy-based scoring
- High throughput format compatible with 96-well plates and automated plate readers
- Well-established regulatory acceptance under ISO 10993-5 and GB/T 16886.5 standards
- Cost-effective reagents and minimal specialized equipment requirements
- Broad applicability across diverse cell lines and sample matrices
Testing Samples
The MTT cytotoxicity evaluation experiment accommodates a broad spectrum of test materials, provided that appropriate extraction and exposure strategies are selected according to ISO 10993-12 sample preparation guidelines.
Medical Device Extracts
Extracts of finished medical devices and their component materials represent the most common sample category. Extracts are prepared by incubating the device or material in a suitable extraction vehicle, such as serum-supplemented Minimum Essential Medium (MEM) or Dulbecco's Modified Eagle Medium (DMEM), physiological saline, or water, under standardized conditions. This approach evaluates the cytotoxic potential of leachable substances released from the product.
Pharmaceutical and Chemical Compounds
Dissolved drug candidates, active pharmaceutical ingredients, excipients, industrial chemicals, and environmental contaminants can be directly diluted into the culture medium across a concentration series, enabling dose-response characterization and IC50 determination.
Biomaterials and Nanomaterials
Cosmetics and Personal Care Products
Ingredients, formulations, and finished cosmetic products are routinely evaluated using the MTT method, and the assay also underpins internationally recognized alternatives to animal eye irritation testing, such as the NRU and related in vitro strategies.
Testing Items
Depending on the study purpose, the MTT cytotoxicity evaluation experiment can deliver the following core test outputs:
- Cell viability percentage: calculated as the ratio of absorbance in treated groups to that of the negative control group
- Cytotoxicity classification: pass or fail determination against the 70 percent viability threshold specified in ISO 10993-5
- IC50 determination: the concentration of a test compound that reduces cell viability by 50 percent, derived from a fitted dose-response curve
- Dose-response curves: full concentration-response relationships across serial dilutions of the test substance
- Time-course profiles: viability assessment at multiple exposure durations such as 24, 48, and 72 hours
- Comparative material ranking: relative cytotoxic potential of candidate materials or product iterations during design optimization
Testing Methods
Sample Preparation and Extraction
For medical device testing, samples are prepared according to ISO 10993-12. Standardized surface-area-to-volume ratios are applied, such as 3 cm² per milliliter for materials with a thickness below 0.5 mm, 1.25 cm² per milliliter for materials between 0.5 and 1.0 mm, 0.5 cm² per milliliter for thicker specimens, 0.2 g per milliliter for irregular porous materials, and 0.1 g per milliliter for absorbent materials. Extraction is typically performed at 37 ± 1 °C for 24 ± 2 hours under agitation in complete culture medium containing serum. For soluble compounds, a geometric dilution series is prepared directly in culture medium, and DMSO stock solutions must be diluted so that the final DMSO concentration does not exceed 0.1 percent.
Cell Seeding and Culture
The mouse fibroblast cell line L929 is the reference cell type recommended by ISO 10993-5 due to its extensive historical use and reproducible sensitivity. Alternatives include NIH/3T3, V79, and BALB/c 3T3 fibroblasts. Cells are routinely cultured in MEM or DMEM supplemented with 5 to 10 percent fetal bovine serum and appropriate antibiotics under standard incubation conditions of 37 °C, 95 percent relative humidity, and a 5 percent carbon dioxide atmosphere. For the assay, cells are seeded into 96-well microplates at a density of approximately 1 × 10⁴ cells per well in 100 microliters of medium and allowed to attach and reach a logarithmic growth phase, typically overnight.
Exposure, MTT Incubation, and Solubilization
Following seeding, the culture medium is replaced with serial dilutions of the test extract or compound, along with the negative control, typically high-density polyethylene, and the positive control, commonly 0.64 percent phenol solution in saline, latex extract, or Triton X-100. Plates are incubated for the designated exposure period, most commonly 24 hours, with parallel groups at 48 and 72 hours when required. After exposure, the medium is carefully removed, and freshly prepared MTT solution, at a concentration of 5 mg/mL in phosphate-buffered saline, is added to achieve a final concentration of approximately 0.5 mg/mL. Plates are incubated for an additional 2 to 4 hours, during which viable cells convert the yellow substrate into purple formazan crystals. The supernatant is then aspirated, and the formazan crystals are dissolved by adding 100 to 150 microliters of DMSO per well, with gentle agitation on a plate shaker until a uniform solution is obtained.
Data Acquisition and Interpretation
Absorbance is measured at 570 nm using a reference wavelength of 630 to 690 nm. Cell viability for each group is calculated using the standard formula: viability percentage equals the absorbance of the treated group minus the blank absorbance, divided by the absorbance of the negative control group minus the blank absorbance, multiplied by 100. Each group is tested with a minimum of three replicate wells, and results are expressed as mean ± standard deviation. According to ISO 10993-5, a test sample is considered cytotoxic if cell viability falls below 70 percent of the negative control. For quantitative dose-response studies, IC50 values are calculated by nonlinear regression, typically using a four-parameter logistic model. Test validity requires positive control viability below 30 percent, negative control viability above 70 percent, and acceptable coefficient of variation among replicate wells.
Applications
The MTT cytotoxicity evaluation experiment serves as a foundational tool across multiple industries and research disciplines:
- Medical device biocompatibility testing for regulatory submission, including catheters, implants, wound dressings, syringes, dental materials, and hemodialysis equipment under ISO 10993-5 and GB/T 16886.5
- Pharmaceutical lead optimization, antitumor drug screening, and structure-activity cytotoxicity profiling during preclinical development
- Nanomaterial biosafety evaluation for nanoparticles, drug delivery carriers, and biomedical coatings
- Cosmetic ingredient and formulation safety assessment consistent with animal-testing alternative strategies
- Food contact material and packaging safety verification
- Environmental toxicology studies assessing water, soil, and air pollutant cytotoxicity
- Academic research on apoptosis, oxidative stress, and cellular stress response mechanisms
FAQ
What is the fundamental principle of the MTT assay?
Living cells with active mitochondrial dehydrogenase enzymes reduce the yellow tetrazolium salt MTT into purple formazan crystals. After solubilization, the absorbance of the resulting solution, measured at approximately 570 nm, is directly proportional to the number of metabolically viable cells, allowing quantitative determination of cytotoxicity.
Which cell line is most commonly used?
The L929 mouse fibroblast cell line is the reference cell type recommended by ISO 10993-5 for medical device cytotoxicity testing, owing to its stable growth characteristics, extensive historical database, and demonstrated sensitivity to a wide range of toxic leachables.
What is the acceptance criterion for cytotoxicity?
According to ISO 10993-5:2009, a test sample is regarded as non-cytotoxic when the mean cell viability of the treated group is greater than or equal to 70 percent of the negative control. Viability below 70 percent indicates cytotoxic potential and typically triggers further evaluation or material reformulation.
How does the MTT assay compare with CCK-8 and MTS methods?
MTS and CCK-8 reagents produce water-soluble formazan products that eliminate the solubilization step and reduce handling time, whereas MTT requires DMSO or isopropanol to dissolve the insoluble crystals. MTT remains the most established method with the largest historical dataset and the lowest reagent cost, while CCK-8 offers greater convenience and lower cytotoxicity of the reagent itself.
What standards govern the MTT cytotoxicity evaluation experiment?
The primary standard is ISO 10993-5, Biological evaluation of medical devices, Part 5: Tests for in vitro cytotoxicity, together with ISO 10993-12 for sample preparation and reference materials. In China, the equivalent national standard is GB/T 16886.5, which is technically aligned with the international standard.
How long does a typical test cycle take?
A standard extract-based MTT test, from cell thawing and expansion through extraction, exposure, staining, and data reporting, generally requires approximately 7 to 10 working days, with the cell exposure phase itself lasting 24 to 72 hours depending on the study design.
What factors can lead to false results?
Test substances that are strongly colored, oxidizing, or reducing may interfere with absorbance readings, and particle suspensions may scatter light or directly reduce MTT. Appropriate blanks containing the test substance without cells, interference controls, and alternative endpoints such as neutral red uptake or resazurin assays should be employed when interference is suspected.